XML 106 R27.htm IDEA: XBRL DOCUMENT
v2.4.0.6

California Institute for Regenerative Medicine Disease Team Therapy Development Awards | 12 Months Ended
--- | ---
Dec. 31, 2012
California Institute for Regenerative Medicine Disease Team Therapy Development Awards [Abstract] |
California Institute for Regenerative Medicine Disease Team Therapy Development Awards | Note 18. California Institute for Regenerative Medicine Disease Team Therapy Development Awards In July 2012, the governing board of the California Institute for Regenerative Medicine (CIRM) approved our application for a Disease Team Therapy Development Research Award for the study of HuCNS-SC cells as a potential treatment for cervical spinal cord injury. Under this disease team program, CIRM would have provided up to $20 million in the form of a forgivable loan. However, in March 2013, we elected not to borrow these funds from CIRM. In September 2012, the governing board of CIRM approved a second award to us for up to $20 million under RFA 10-05. The award is to fund preclinical development of our proprietary HuCNS-SC cells in Alzheimer’s disease over a maximum four-year period, with the goal of filing an IND in that time. Negotiation of terms and conditions for this forgivable loan is on-going.

X
- Details
Name: | stem_CaliforniaInstituteForRegenerativeMedicineDiseaseTeamTherapyDevelopmentAwardsAbstract
Namespace Prefix: | stem_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition California institute for regenerative medicine disease team therapy development awards. + References No definition available. + Details
Name: | stem_CaliforniaInstituteForRegenerativeMedicineDiseaseTeamTherapyDevelopmentAwardsTextBlock
Namespace Prefix: | stem_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration